Arcutis Biotherapeutics Inc.

ARQT | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.96

+$0.58 (+2.29%)

At close: Sep 21, 2026, 4:00 PM ET

$26.06

+$0.10 (+0.39%)

Pre-market: Sep 22, 2026, 8:52 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	376.07M	196.54M	59.61M	3.69M	n/a	n/a
Cost of Revenue	36.7M	19.13M	4.99M	754K	763K	455K
Gross Profit	339.38M	177.41M	54.62M	2.93M	-763K	-455K
Operating Income	-12.23M	-128.4M	-241.1M	-301.63M	-206.53M	-136.65M
Interest Income	n/a	n/a	n/a	n/a	173K	967K
Pretax Income	-14.97M	-139.39M	-259.03M	-311.46M	-206.36M	-135.68M
Net Income	-16.14M	-140.04M	-262.14M	-311.46M	-206.36M	-135.68M
Selling & General & Admin	274.55M	229.39M	185.15M	122.12M	60.97M	20.88M
Research & Development	77.05M	76.42M	110.58M	182.44M	145.56M	115.31M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	351.6M	305.81M	295.72M	304.56M	205.77M	136.19M
Interest Expense	12.08M	27.17M	29.71M	15.65M	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	388.3M	324.94M	300.71M	305.31M	206.53M	136.65M
Income Tax Expense	1.17M	647K	3.11M	n/a	n/a	n/a
Shares Outstanding (Basic)	127.23M	120.96M	69.31M	55.03M	49.41M	35.67M
Shares Outstanding (Diluted)	127.23M	120.96M	69.31M	55.03M	49.41M	35.67M
EPS (Basic)	-0.13	-1.16	-3.78	-5.66	-4.17	-3.80
EPS (Diluted)	-0.13	-1.16	-3.78	-5.66	-4.17	-3.80
EBITDA	2.48M	-109.63M	-227.43M	-294.55M	-205.59M	-135.22M
EBIT	-2.89M	-112.22M	-229.32M	-295.81M	-206.36M	-135.68M
Depreciation & Amortization	5.37M	2.6M	1.88M	1.25M	763K	455K